Himalaya enters mothercare segment; eyes 6% sales in 2 years

Representative image
Herbal wellness and personal care firm Himalaya Drug Company on Tuesday announced foray into the mothercare segment with the launch of a range of products and is eyeing up to six per cent contribution in its turnover in two years time.

"We have forayed into the mothercare segment with a dedicated range of herbal products for women to be used before and after pregnancy... We expect mothercare segment to contribute five-six per cent in our turnover in two years time," Himalaya Drug Company CEO Philipe Haydon told PTI.

The company, which reported a turnover of Rs 1,800 crore in the previous fiscal, is looking at Rs 2,100 crore sales in the current fiscal, Haydon said.

At present, Himalaya's biggest vertical of personal care contributes 42 per cent to its total sales, followed by pharmaceutical 32 per cent, baby care 15 per cent, animal health 4 per cent and wellness 4 per cent.

On more launches, he said: "We have entered the segment with four products and we will launch another seven-eight products over the next one year... We are hoping to be a benchmark in the mother personal care space."

When asked if the company is looking at raising funds to support its aggressive expansion plans, Haydon said: "We have been very active in the last one year with new launches but we fund all our expansion through internal accruals. We have no plans to raise funds."

Initially, the company has launched four products targeting mothers and will promote it through its network of gynaecologists and neonatologists. The products will be available in medical stores, supermarkets and modern trades outlets.


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel